Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Testosterone in Female Hypoactive Sexual Desire Disorder
This study has been completed.
Study NCT00140153 Information provided by Beersheva Mental Health Center
First Received on August 31, 2005. Last Updated on November 23, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypoactive Sexual Desire Disorder
Additional conditions recognized in this trial
Hypokinesia
Sexual Dysfunctions, Psychological
More general conditions related to this trial
Dyskinesias
Mental Disorders
Nervous System Diseases
Neurologic Manifestations
Sexual and Gender Disorders
Signs and Symptoms
Interventions listed in this trial
testosterone gel (Androgel)
Additional drug interventions recognized in this trial
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Beersheva Mental Health Center
Back to top of Main Content
